A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
Authors
Keywords
-
Journal
STATISTICS IN MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-15
DOI
10.1002/sim.7811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging
- (2016) Karra D. Harrington et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning
- (2016) Jason Hassenstab et al. NEUROBIOLOGY OF AGING
- A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease
- (2015) Hong Liu-Seifert et al. PLoS One
- Estimating long-term multivariate progression from short-term data
- (2014) Michael C. Donohue et al. Alzheimers & Dementia
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
- (2014) D. C. Ryman et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
- (2013) Bruno Vellas et al. Alzheimers & Dementia
- Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).
- (2013) Martha Storandt et al. NEUROPSYCHOLOGY
- Combining Multiple Markers to Improve the Longitudinal Rate of Progression: Application to Clinical Trials on the Early Stage of Alzheimer's Disease
- (2013) Chengjie Xiong et al. Statistics in Biopharmaceutical Research
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer’s disease
- (2011) Chengjie Xiong et al. Clinical Trials
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- Recent developments in Alzheimer's disease therapeutics
- (2009) Michael S Rafii et al. BMC Medicine
- The Delayed-Start Study Design
- (2009) Ralph B. D'Agostino NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started